Heidi Health is an Ambient Clinical AI company founded in 2021 and based in Melbourne, Australia. It has raised $436.6M in total funding, most recently a Series C in 2026 at a $900M valuation.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Sep 22, 2026 | Series C | $100M | $900M | Blackbird |
Heidi's AI scribe listens to a patient visit and drafts the clinical note, a patient summary and follow-up tasks, using templates clinicians set up to match their own style. It runs in the browser, on iOS and Android, and in Heidi Desktop for macOS and Windows, which also captures telehealth audio from the call. A free tier lets individual clinicians start without a contract.
Heidi Evidence gives clinicians context-aware clinical guidelines at the point of care, inside the same product as the scribe. Heidi launched it in March 2026 and said in September 2026 that it had answered more than 10M queries.
Remote is a wearable device that captures visit audio for Heidi in care settings away from a desk or computer. Heidi ships it to select regions and takes early-access sign-ups in other markets.
Heidi II, introduced on Sept. 28, 2026, adds AI agents that take on visit administration so clinicians spend more of the visit with patients. Heidi said in September 2026 that its agentic features would not be offered in the UK or EU.
No recently verified openings are available right now. The company's careers page has the latest.
View all careers ↗